Endogenous Protein Tagging in Human Induced Pluripotent Stem Cells Using CRISPR/Cas9

被引:12
|
作者
Haupt, Amanda [1 ]
Grancharova, Tanya [1 ]
Arakaki, Joy [1 ]
Fuqua, Margaret A. [1 ]
Roberts, Brock [1 ]
Gunawardane, Ruwanthi N. [1 ]
机构
[1] Allen Inst Cell Sci, Seattle, WA 98109 USA
来源
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS | 2018年 / 138期
关键词
Genetics; Issue; 138; Stem Cells; hiPSC; Molecular Biology; CRISPR; Cas9; Genome Engineering; Gene Knock-in; Gene Tagging; Fluorescent Protein; WEB TOOL; GENOME; CAS9; CHALLENGES; GENERATION; NUCLEASES; CHOPCHOP; DELIVERY; TALENS; ZFNS;
D O I
10.3791/58130
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
A protocol is presented for generating human induced pluripotent stem cells (hiPSCs) that express endogenous proteins fused to in-frame N- or C-terminal fluorescent tags. The prokaryotic CRISPR/Cas9 system (clustered regularly interspaced short palindromic repeats/CRISPR-associated 9) may be used to introduce large exogenous sequences into genomic loci via homology directed repair (HDR). To achieve the desired knock-in, this protocol employs the ribonucleoprotein (RNP)-based approach where wild type Streptococcus pyogenes Cas9 protein, synthetic 2-part guide RNA (gRNA), and a donor template plasmid are delivered to the cells via electroporation. Putatively edited cells expressing the fluorescently tagged proteins are enriched by fluorescence activated cell sorting (FACS). Clonal lines are then generated and can be analyzed for precise editing outcomes. By introducing the fluorescent tag at the genomic locus of the gene of interest, the resulting subcellular localization and dynamics of the fusion protein can be studied under endogenous regulatory control, a key improvement over conventional overexpression systems. The use of hiPSCs as a model system for gene tagging provides the opportunity to study the tagged proteins in diploid, nontransformed cells. Since hiPSCs can be differentiated into multiple cell types, this approach provides the opportunity to create and study tagged proteins in a variety of isogenic cellular contexts.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Simple Meets Single: The Application of CRISPR/Cas9 in Haploid Embryonic Stem Cells
    Yin, Zixi
    Chen, Lingyi
    STEM CELLS INTERNATIONAL, 2017, 2017
  • [22] Evaluation of CRISPR/Cas9 exon-skipping vector for choroideremia using human induced pluripotent stem cell-derived RPE
    Iwagawa, Toshiro
    Masumoto, Hiroki
    Tabuchi, Hitoshi
    Tani, Kenzaburo
    Conklin, Bruce R.
    Watanabe, Sumiko
    JOURNAL OF GENE MEDICINE, 2023, 25 (02)
  • [23] Deciphering Common Long QT Syndrome Using CRISPR/Cas9 in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
    Song, Yongfei
    Zheng, Zequn
    Lian, Jiangfang
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [24] CRISPR/Cas9 genome editing in human hematopoietic stem cells
    Bak, Rasmus O.
    Dever, Daniel P.
    Porteus, Matthew H.
    NATURE PROTOCOLS, 2018, 13 (02) : 358 - 376
  • [25] Homologous recombination in human embryonic stem cells using CRISPR/Cas9 nickase and a long DNA donor template
    Rong, Zhili
    Zhu, Shengyun
    Xu, Yang
    Fu, Xuemei
    PROTEIN & CELL, 2014, 5 (04) : 258 - 260
  • [26] CRISPR/Cas9 gene correction of HbH-CS thalassemia-induced pluripotent stem cells
    Xie Yingjun
    Xie Yuhuan
    Chen Yuchang
    Li Dongzhi
    Wang Ding
    Song Bin
    Yang Yi
    Lu Dian
    Xue Yanting
    Xiong Zeyu
    Liu Nengqing
    Chen Diyu
    Sun Xiaofang
    ANNALS OF HEMATOLOGY, 2019, 98 (12) : 2661 - 2671
  • [27] CRISPR/Cas9 Editing of Murine Induced Pluripotent Stem Cells for Engineering Inflammation-Resistant Tissues
    Brunger, Jonathan M.
    Zutshi, Ananya
    Willard, Vincent P.
    Gersbach, Charles A.
    Guilak, Farshid
    ARTHRITIS & RHEUMATOLOGY, 2017, 69 (05) : 1111 - 1121
  • [28] Toward a CRISPR Picture: Use of CRISPR/Cas9 to Model Diseases in Human Stem Cells In Vitro
    Freiermuth, Jamie L.
    Powell-Castilla, Ian J.
    Gallicano, G. Ian
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2018, 119 (01) : 62 - 68
  • [29] Trichostatin A for Efficient CRISPR-Cas9 Gene Editing of Human Pluripotent Stem Cells
    Molugu, Kaivalya
    Khajanchi, Namita
    Lazzarotto, Cicera R.
    Tsai, Shengdar Q.
    Saha, Krishanu
    CRISPR JOURNAL, 2023, 6 (05): : 473 - 485
  • [30] Efficient Ablation of Genes in Human Hematopoietic Stem and Effector Cells using CRISPR/Cas9
    Mandal, Pankaj K.
    Ferreira, Leonardo M. R.
    Collins, Ryan
    Meissner, Torsten B.
    Boutwell, Christian L.
    Friesen, Max
    Vrbanac, Vladimir
    Garrison, Brian S.
    Stortchevoi, Alexei
    Bryder, David
    Musunuru, Kiran
    Brand, Harrison
    Tager, Andrew M.
    Allen, Todd M.
    Talkowski, Michael E.
    Rossi, Derrick J.
    Cowan, Chad A.
    CELL STEM CELL, 2014, 15 (05) : 643 - 652